Global Smart Nebulizer Market

Report ID : 1311 | Published : 2022-08-01 | Pages: | Format: PDF/EXCEL

The market size of the Global Smart Nebulizer Market in the year 2021 is valued at 255.49 million and is predicted to reach 738.91 million by the year 2030 at an 12.8% CAGR during the forecast period.

The global healthcare sector is developing to see broad use of nebulizers as a key treatment option for asthma and COPD; the primary demand drivers are an increase in chronic respiratory and associated disorders as well as a rise in demand for and adoption of home healthcare products. In this backdrop, the market for Smart Nebulizers is expected to increase significantly in the following years. Modern technology-enabled nebulizers could be the next major contributor to the growth of the smart nebulizers industry. The availability of alternatives such as Metered-Dose-Inhaler (MDI) and the usage of oral drugs have posed significant barriers to the growth in the adoption of smart nebulizers. To effectively compete with other competitors, prominent companies in the global smart nebulizers market are launching a new product. With the incorporation of cloud computing into nebulizers becoming more prevalent, industry participants expected to invest in the portfolio. Home care nebulizers are expected to gain popularity during the predicted period. Smart Nebulizers Companies are working with a sense of urgency and a consumer focus. Continued innovation supports growth in the worldwide Smart Nebulizers market.

Market Segmentation:

The Smart Nebulizer market is segmented based on the therapeutic areas, component, type of patients and end-users. Based on therapeutic areas, the market is segmented into Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Cystic FibrosisBased on components, the market is segmented as Nebulizer Device, Associated App and Consumables. By types of patients, the market is segmented into Adult Patients and Pediatric Patients. Based on end-users, the market is segmented as hospitals, emergency centres and home healthcare centres.

Based on end-users, the hospitals' segment is accounted as a major contributor in the Smart Nebulizer market.

The hospitals' category is expected to hold a major share in the global Smart Nebulizer market in 2021. because of favorable reimbursement policies and increased patient traffic, Hospitals are an essential component of the healthcare business and the primary source of revenue for the whole industry. As a result, several corporations make significant efforts, both in terms of marketing tactics and income, to promote their products/services in hospitals.

Nebulizer segment witnessed growth at a rapid rate.

The nebulizer segment is projected to proliferate in the global Smart Nebulizer market. The simple and cheap availability of land in developing nations can be related to the shifting manufacture of nebulizer devices. The adoption of newly developed nebulizers with quick medicine delivery combined with a high-end technical assessment with more precision is gaining momentum among the US population, boosting the growth of the global nebulizer devices market, especially in countries such as the US, Germany, the UK, China, and India.

The North America Smart Nebulizer market holds a significant revenue share in the region.

The North America Smart Nebulizer market is expected to register the highest market share in terms of revenue soon. Due to the rising prevalence of asthma and Chronic Obstructive Pulmonary Disease (COPD) in the United States, North America is expected to emerge as a significant growth contributor to the smart nebulizers market. The easy and inexpensive availability of land in emerging nations can be related to the shifting manufacture of nebulizer devices. With significant commercial possibilities in the Asia Pacific, enterprises are concentrating on expanding their product portfolios, diversifying their business operations, lowering costs, increasing customer happiness, and improving the dependability of Smart Nebulizers. The need for Smart Nebulizers is predicted to grow as the number of smokers and pollution levels rise.

Competitive Landscape

The key players in the Smart Nebulizer market have shifted their focus towards bio-based components for product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the Smart Nebulizer market are AireHealth, Becton Dickinson & Company, BioPlus, BPL Medical Technologies, Briggs Healthcare, Briutcare, BriutCare, CA-MI s.r.l., Contec Medical Systems Co.Ltd, DeVilbiss Healthcare L.L.C., FaceLake, Fahl Medizintechnik-Vertrieb GmbH, Guangdong Delong Intelligent Technology CO., Ltd., Hans Dinslage Gmbh, Koninklijke Philips N.V., LAICA International Corporation, Lycome international Industry, MedTech, Microlife AG, Omron Corporation, Ozocheck, PARI Pharma, Pulmotree Medical GMBH, SmartCare, SOMATCO, Sunset Healthcare Solutions Inc., Taidoc Technology Corporation, Vapo Health, Vectura, Wuhan W.E.O. Science & Technology Development, YirDocand and other prominent players.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Smart Nebulizer Market Snapshot

Chapter 4. Global Smart Nebulizer Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Therapeutic Areas Estimates & Trend Analysis

5.1. By Therapeutic Areas & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Therapeutic Areas:

5.2.1. Asthma

5.2.2. Chronic Obstructive Pulmonary Disease (COPD)

5.2.3. Cystic Fibrosis

Chapter 6. Market Segmentation 2: By Component Estimates & Trend Analysis

6.1. By Component & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Component:

6.2.1. Nebulizer Device

6.2.2. Associated App

6.2.3. Consumables

Chapter 7. Market Segmentation 3: By Type of Patients Estimates & Trend Analysis

7.1. By Type of Patients & Market Share, 2020 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Type of Patients:

7.2.1. Adult Patients

7.2.2. Pediatric Patients

Chapter 8. Market Segmentation 4: By End-user Estimates & Trend Analysis

8.1. By End-user & Market Share, 2020 & 2030

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-user:

8.2.1. Hospitals

8.2.2. Emergency Centers

8.2.3. Home Healthcare Settings

Chapter 9. Smart Nebulizer Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Smart Nebulizer Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas, 2020-2030

9.1.2. North America Smart Nebulizer Market revenue (US$ Million) estimates and forecasts By Component, 2020-2030

9.1.3. North America Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by Type of Patients, 2020-2030

9.1.4. North America Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by End-user, 2020-2030

9.1.5. North America Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

9.2. Europe

9.2.1. Europe Smart Nebulizer Market revenue (US$ Million) By Therapeutic Areas, 2020-2030

9.2.2. Europe Smart Nebulizer Market revenue (US$ Million) By Component, 2020-2030

9.2.3. Europe Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by Type of Patients, 2020-2030

9.2.4. Europe Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by End-user, 2020-2030

9.2.5. Europe Smart Nebulizer Market revenue (US$ Million) by country, 2020-2030

9.3. Asia Pacific

9.3.1. Asia Pacific Smart Nebulizer Market revenue (US$ Million) By Therapeutic Areas, 2020-2030

9.3.2. Asia Pacific Smart Nebulizer Market revenue (US$ Million) By Component, 2020-2030

9.3.3. Asia Pacific Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by Type of Patients, 2020-2030

9.3.4. Asia Pacific Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by End-user, 2020-2030

9.3.5. Asia Pacific Smart Nebulizer Market revenue (US$ Million) by country, 2020-2030

9.4. Latin America

9.4.1. Latin America Smart Nebulizer Market revenue (US$ Million) By Therapeutic Areas, (US$ Million)

9.4.2. Latin America Smart Nebulizer Market revenue (US$ Million) By Component, (US$ Million)

9.4.3. Latin America Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by Type of Patients, 2020-2030

9.4.4. Latin America Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by End-user, 2020-2030

9.4.5. Latin America Smart Nebulizer Market revenue (US$ Million) by country, 2020-2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Smart Nebulizer Market revenue (US$ Million) By Therapeutic Areas, (US$ Million)

9.5.2. Middle East & Africa Smart Nebulizer Market revenue (US$ Million) By Component, (US$ Million)

9.5.3. Middle East & Africa Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by Type of Patients, 2020-2030

9.5.4. Middle East & Africa Smart Nebulizer Market revenue (US$ Million) estimates and forecasts by End-user, 2020-2030

9.5.5. Middle East & Africa Smart Nebulizer Market revenue (US$ Million) by country, 2020-2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. AireHealth

10.2.2. Becton Dickinson & Company

10.2.3. BioPlus

10.2.4. BPL Medical Technologies

10.2.5. Briggs Healthcare

10.2.6. Briutcare

10.2.7. BriutCare

10.2.8. CA-MI s.r.l.

10.2.9. Contec Medical Systems Co.Ltd

10.2.10. DeVilbiss Healthcare L.L.C.

10.2.11. FaceLake

10.2.12. Fahl Medizintechnik-Vertrieb GmbH

10.2.13. Guangdong Delong Intelligent Technology CO., Ltd.

10.2.14. Hans Dinslage Gmbh

10.2.15. Koninklijke Philips N.V.

10.2.16. LAICA International Corporation

10.2.17. Lycome international Industry

10.2.18. MedTech

10.2.19. Microlife AG

10.2.20. Omron Corporation

10.2.21. Ozocheck

10.2.22. PARI Pharma

10.2.23. Pulmotree Medical GMBH

10.2.24. SmartCare

10.2.25. SOMATCO

10.2.26. Sunset Healthcare Solutions Inc.

10.2.27. Taidoc Technology Corporation

10.2.28. Vapo Health

10.2.29. Vectura

10.2.30. Wuhan W.E.O. Science & Technology Development

10.2.31. YirDoc

10.2.32. Other Prominent Players

Segmentation of Smart Nebulizer Market-

Therapeutic Areas

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis

Component

  • Nebulizer Device
  • Associated App
  • Consumables

Type of Patients

  • Adult Patients
  • Pediatric Patients

End-User

  • Hospitals
  • Emergency Centers
  • Home Healthcare Settings"

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global Smart Nebulizer Market?

2021 is valued at 255.49 million and is predicted to reach 738.91 million by the year 2030

an 12.8% CAGR during the forecast period.

Our Clients